Oral Wegovy: What to Know Before Starting the New Weight Loss Pill

Am I a candidate for this medication based on my medical history?

Oral Wegovy is generally prescribed for adults with a body mass index (BMI) of 30 or higher, or 27 or higher with weight-related conditions like high blood pressure or high cholesterol. Patients who are pregnant or have a personal or family history of thyroid cancer, pancreatitis, severe gastrointestinal disease, or certain endocrine disorders are not eligible. A healthcare provider should review your medical history, medications, and goals to confirm eligibility, and pharmacists should check for drug interactions and counsel the patient on proper use and storage.

How much weight loss is realistic for me?

In the largest study of oral Wegovy (OASIS-4), participants lost 13.6 percent of their starting body weight over 64 weeks when combined with diet and lifestyle changes. For example, someone who weighs 250 pounds could expect to lose roughly 35 pounds when using the product as prescribed, though these numbers reflect average weight lost in trials and are not guaranteed. Weight loss occurs gradually over months and eventually plateaus; some patients will lose more, some will lose less, and some may discontinue treatment altogether because of side effects. The medication helps regulate appetite, but patients should still continue to follow healthy eating patterns and engage in physical activity. Patients should be aware that stopping treatment may result in weight gain, and this should be part of their conversation with the healthcare team.

How should I time this pill with my other morning medications, and how should I store it?

Oral Wegovy should be taken first thing in the morning with no more than four ounces of plain water. Patients should wait at least 30 minutes before eating, drinking anything else, or taking any other oral medications. If these instructions are not followed, the drug may not be absorbed adequately and may not work as well as it could. The tablets are sensitive to moisture and should remain in their original container, which means they should not be stored in a weekly pill organizer. Taking medications as prescribed is an area where you pharmacist can be particularly helpful. They can help patients reorganize morning medication schedules, identify potential conflicts, and ensure that other prescriptions are timed safely.

What side effects should I expect during dose increases?

Patients should gradually increase their dose from the starting 1.5mg a day all the way up to 25mg a day, which may take 90 days or longer to do. During the escalation period, nausea is the most common side effect; other effects such as vomiting, diarrhea, constipation, and abdominal discomfort may also occur. To minimize these, the dose is gradually increased over several months, and many patients notice their symptoms improve over time. To reduce the likelihood of symptoms, patients should eat smaller, more frequent meals and avoid heavy, high-fat foods. Although uncommon, serious problems such as pancreatitis or gallbladder issues can occur, which is why persistent or severe abdominal pain should be reported promptly.

Pharmacists often counsel patients during dose changes and can provide tips and strategies to manage side effects.

What patient assistance programs are available to help me afford my medication?

Pharmacists frequently help patients understand their insurance coverage, explore manufacturer savings options, and explain the process of obtaining and renewing authorizations. Oral Wegovy could cost as much as $1,600 (REDBOOK AWP Price, March 1, 2026) per month before insurance. Coverage varies widely, and many insurance plans require prior approval from the prescriber; even if obtained, patients may still be responsible for a substantial copay or co-insurance. The manufacturer offers savings programs for certain patients with commercial insurance, and some individuals may also qualify for income-based assistance programs. There are now programs for commercial insurance patients and self-pay patients to obtain the drug directly through the manufacturer. Eligibility rules may change over time, and patients may find their coverage varies month to month.

If this does not work for me, what are the next options?

If oral Wegovy does not provide sufficient weight loss or causes side effects that are difficult to tolerate, patients may try the injectable Wegovy. Check out our article with an overview of common Wegovy and Ozempic questions answered by our pharmacy experts. Tirzepatide, marketed as Zepbound for weight loss, works on two hormone pathways (GLP-1 AND GIP) and has shown greater average weight loss in some studies. Because new therapies continue to be approved, it’s important to periodically review what’s available. Orforglipron, an oral GLP-1-based medication under development, could become another option if approved.

Oral Wegovy provides a non-injectable, proven GLP-1 medication that, when combined with lifestyle changes, supports significant weight loss. Everyone on the healthcare team has a role to play: physicians diagnose and initiate treatment, while pharmacists offer medication counseling, manage side effects, and assist with insurance and costs. As weight-loss options grow, staying informed helps patients make choices that suit their health and their needs.